Home HIV FAQ My Amedeo About Flying Publisher   

Amedeo Prize 2008
The 21 Finalists


  Prostate Cancer

 

Free Subscription


26.03.2008

1 Am J Clin Pathol
3 Br J Cancer
2 Cancer
2 Clin Cancer Res
5 Eur Urol
2 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Nucl Med
20 J Urol
1 Lancet Oncol
1 N Engl J Med
1 Oncol Rep
1 Proc Natl Acad Sci U S A
4 Prog Urol
10 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. LEERS MP , Nap M, Herwig R, Delaere K, et al
    Circulating PSA-Containing Macrophages as a Possible Target for the Detection of Prostate Cancer: A Three-Color/Five-Parameter Flow Cytometric Study on Peripheral Blood Samples.
    Am J Clin Pathol. 2008;129:649-56.
    PubMed     Related articles    Abstract available


    Br J Cancer

  2. EWALD JA , Desotelle JA, Almassi N, Jarrard DF, et al
    Drug-induced senescence bystander proliferation in prostate cancer cells in vitro and in vivo.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available

  3. KHANDELWAL A , Gediya LK, Njar VC
    MS-275 synergistically enhances the growth inhibitory effects of RAMBA VN/66-1 in hormone-insensitive PC-3 prostate cancer cells and tumours.
    Br J Cancer. 2008;.
    PubMed     Related articles    Abstract available

  4. MCCALL P , Gemmell LK, Mukherjee R, Bartlett JM, et al
    Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients.
    Br J Cancer. 2008;98:1094-101.
    PubMed     Related articles    Abstract available


    Cancer

  5. SMITH MR , Lee H, McGovern F, Fallon MA, et al
    Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer: differences from the classic metabolic syndrome.
    Cancer. 2008;.
    PubMed     Related articles    Abstract available

  6. SONPAVDE G , Garzotto M, Chi KN
    Reply to neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.
    Cancer. 2008;.
    PubMed     Related articles   


    Clin Cancer Res

  7. KOSARI F , Munz JM, Savci-Heijink CD, Spiro C, et al
    Identification of prognostic biomarkers for prostate cancer.
    Clin Cancer Res. 2008;14:1734-43.
    PubMed     Related articles    Abstract available

  8. LOGOTHETIS CJ , Navone NM, Lin SH
    Understanding the biology of bone metastases: key to the effective treatment of prostate cancer.
    Clin Cancer Res. 2008;14:1599-602.
    PubMed     Related articles    Abstract available


    Eur Urol

  9. TERRIS MK
    Editorial Comment on: Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer In Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Eur Urol. 2008;.
    PubMed     Related articles   

  10. WOLTERS T , Roobol MJ, Bangma CH, Schroder FH, et al
    Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer in Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available

  11. ALCARAZ A
    Management of the Hormone Sensitivity of Prostate Cancer: Where Are We Now?
    Eur Urol. 2008;.
    PubMed     Related articles   

  12. VAN AS NJ , Norman AR, Thomas K, Khoo VS, et al
    Predicting the Probability of Deferred Radical Treatment for Localised Prostate Cancer Managed by Active Surveillance.
    Eur Urol. 2008;.
    PubMed     Related articles    Abstract available

  13. ADOLFSSON J
    Editorial Comment on: Predicting the Probability of Deferred Radical Treatment for Localised Prostate Cancer Managed by Active Surveillance.
    Eur Urol. 2008;.
    PubMed     Related articles   


    Int J Radiat Oncol Biol Phys

  14. LIM TS , Cheung PC, Loblaw DA, Morton G, et al
    Hypofractionated Accelerated Radiotherapy Using Concomitant Intensity-Modulated Radiotherapy Boost Technique for Localized High-Risk Prostate Cancer: Acute Toxicity Results.
    Int J Radiat Oncol Biol Phys. 2008;.
    PubMed     Related articles    Abstract available

  15. CHAN LW , Xia P, Gottschalk AR, Akazawa M, et al
    Proposed Rectal Dose Constraints for Patients Undergoing Definitive Whole Pelvic Radiotherapy for Clinically Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2008;.
    PubMed     Related articles    Abstract available


    J Clin Oncol

  16. FLAIG TW , Tangen CM, Hussain MH, Stadler WM, et al
    Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial.
    J Clin Oncol. 2008;26:1532-6.
    PubMed     Related articles    Abstract available


    J Natl Cancer Inst

  17. DAS IJ , Cheng CW, Chopra KL, Mitra RK, et al
    Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
    J Natl Cancer Inst. 2008;100:300-7.
    PubMed     Related articles    Abstract available   Free Full Text


    J Nucl Med

  18. KONO Y , Kubota K, Mitsumoto T, Tanaka A, et al
    Scintigraphic Detection of 125I Seeds After Permanent Brachytherapy for Prostate Cancer.
    J Nucl Med. 2008;.
    PubMed     Related articles    Abstract available


    J Urol

  19. HIRATA H , Hinoda Y, Kawamoto K, Kikuno N, et al
    Mismatch Repair Gene MSH3 Polymorphism is Associated With the Risk of Sporadic Prostate Cancer.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available

  20. NAKANISHI H , Groskopf J, Fritsche HA, Bhadkamkar V, et al
    PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available

  21. PATEL MI , Kurek C, Dong Q
    The Arachidonic Acid Pathway and its Role in Prostate Cancer Development and Progression.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available

  22. KONETY BR , Cowan JE, Carroll PR
    Patterns of Primary and Secondary Therapy for Prostate Cancer in Elderly Men: Analysis of Data From CaPSURE((R)).
    J Urol. 2008;.
    PubMed     Related articles    Abstract available

  23. SIM HG , Telesca D, Culp SH, Ellis WJ, et al
    Tertiary Gleason Pattern 5 in Gleason 7 Prostate Cancer Predicts Pathological Stage and Biochemical Recurrence.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available

  24. KATTAN MW
    Predicting Prostate Cancer Behavior-What is a Urologist to Do?
    J Urol. 2008;.
    PubMed     Related articles   

  25. RHODEN EL , Riedner CE, Morgentaler A
    The Ratio of Serum Testosterone-to-Prostate Specific Antigen Predicts Prostate Cancer in Hypogonadal Men.
    J Urol. 2008;.
    PubMed     Related articles    Abstract available

  26. HALAT SK , MacLennan GT
    Adenoid cystic/basal cell carcinoma of the prostate.
    J Urol. 2008;179:1576.
    PubMed     Related articles   

  27. HALTER RJ , Schned A, Heaney J, Hartov A, et al
    Electrical impedance spectroscopy of benign and malignant prostatic tissues.
    J Urol. 2008;179:1580-6.
    PubMed     Related articles    Abstract available

  28. DERAS IL , Aubin SM, Blase A, Day JR, et al
    PCA3: a molecular urine assay for predicting prostate biopsy outcome.
    J Urol. 2008;179:1587-92.
    PubMed     Related articles    Abstract available

  29. SHARIAT SF , Walz J, Roehrborn CG, Montorsi F, et al
    Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.
    J Urol. 2008;179:1593-7.
    PubMed     Related articles    Abstract available

  30. FINE SW , Epstein JI
    A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score.
    J Urol. 2008;179:1335-8.
    PubMed     Related articles    Abstract available

  31. THOMPSON RH , Leibovich BC, Karnes RJ, Bergstralh EJ, et al
    Radical retropubic prostatectomy in immunosuppressed transplant recipients.
    J Urol. 2008;179:1349-52.
    PubMed     Related articles    Abstract available

  32. BOORJIAN SA , Karnes RJ, Rangel LJ, Bergstralh EJ, et al
    Mayo Clinic validation of the D'amico risk group classification for predicting survival following radical prostatectomy.
    J Urol. 2008;179:1354-60.
    PubMed     Related articles    Abstract available

  33. NEILL MG , Toi A, Lockwood GA, Evans A, et al
    Systematic lateral prostate biopsy--are the benefits worth the costs?
    J Urol. 2008;179:1321-6.
    PubMed     Related articles    Abstract available

  34. SCATTONI V , Roscigno M, Raber M, Deho F, et al
    Initial extended transrectal prostate biopsy--are more prostate cancers detected with 18 cores than with 12 cores?
    J Urol. 2008;179:1327-31.
    PubMed     Related articles    Abstract available

  35. LARSON BT , Magi-Galluzzi C, Casey G, Plummer SJ, et al
    Pathological aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants.
    J Urol. 2008;179:1344-8.
    PubMed     Related articles    Abstract available

  36. CHOUEIRI TK , Dreicer R, Paciorek A, Carroll PR, et al
    A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy.
    J Urol. 2008;179:906-10.
    PubMed     Related articles    Abstract available

  37. PAVLOVICH CP , Trock BJ, Sulman A, Wagner AA, et al
    3-year actuarial biochemical recurrence-free survival following laparoscopic radical prostatectomy: experience from a tertiary referral center in the United States.
    J Urol. 2008;179:917-21.
    PubMed     Related articles    Abstract available

  38. MUSCH M , Klevecka V, Roggenbuck U, Kroepfl D, et al
    Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006.
    J Urol. 2008;179:923-8.
    PubMed     Related articles    Abstract available


    Lancet Oncol

  39. VERGIS R , Corbishley CM, Norman AR, Bartlett J, et al
    Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: a retrospective analysis of two randomised radiotherapy trials and one surgical cohort study.
    Lancet Oncol. 2008;.
    PubMed     Related articles    Abstract available


    N Engl J Med

  40. SANDA MG , Dunn RL, Michalski J, Sandler HM, et al
    Quality of life and satisfaction with outcome among prostate-cancer survivors.
    N Engl J Med. 2008;358:1250-61.
    PubMed     Related articles    Abstract available


    Oncol Rep

  41. BRONZETTI E , Artico M, Forte F, Pagliarella G, et al
    A possible role of BDNF in prostate cancer detection.
    Oncol Rep. 2008;19:969-974.
    PubMed     Related articles    Abstract available


    Proc Natl Acad Sci U S A

  42. PENG Y , Chen F, Melamed J, Chiriboga L, et al
    Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer.
    Proc Natl Acad Sci U S A. 2008;.
    PubMed     Related articles    Abstract available


    Prog Urol

  43. FLAMAND V , Zini L, Salleron J, Fantoni JC, et al
    [Observational survey on variations of prostate cancer incidence by stage in the Nord-Pas-de-Calais region between 1998 and 2004.]
    Prog Urol. 2008;18:53-59.
    PubMed     Related articles    Abstract available

  44. GUY L , van de Steene E, Vedrine N, Teissonniere M, et al
    [General practical survey of individual prostate cancer screening.]
    Prog Urol. 2008;18:46-52.
    PubMed     Related articles    Abstract available

  45. CHARGARI C , Vedrine L, Bauduceau O, Le Moulec S, et al
    [Prostate cancer and disseminated intravascular coagulation: Review of the literature.]
    Prog Urol. 2008;18:9-13.
    PubMed     Related articles    Abstract available

  46. PEYROMAURE M , Rebillard X, Ruffion A, Salomon L, et al
    [Time-course of plasma testosterone in patients with prostate cancer treated by endocrine therapy.]
    Prog Urol. 2008;18:2-8.
    PubMed     Related articles    Abstract available


    Urology

  47. SUMITOMO M , Hayashi M, Watanabe T, Tsugawa M, et al
    Efficacy of Short-Term Androgen Deprivation with High-Intensity Focused Ultrasound in the Treatment of Prostate Cancer in Japan.
    Urology. 2008;.
    PubMed     Related articles    Abstract available

  48. BELLIZZI KM , Latini DM, Cowan JE, Duchane J, et al
    Fear of Recurrence, Symptom Burden, and Health-Related Quality of Life in Men with Prostate Cancer.
    Urology. 2008;.
    PubMed     Related articles    Abstract available

  49. MEEKS JJ , Habermacher GM, Le B, Smith ND, et al
    Delayed Diagnosis of Prostate Cancer with Neuroendocrine Differentiation after Laser TURP.
    Urology. 2008;.
    PubMed     Related articles    Abstract available

  50. TAKECHI H , Ito K, Yamamoto T, Miyakubo M, et al
    Prostate-Specific Antigen Kinetics in Screen-Detected Prostate Cancer in Japan.
    Urology. 2008;.
    PubMed     Related articles    Abstract available

  51. LUND L , Borre M, Jacobsen J, Sorensen HT, et al
    Impact of Comorbidity on Survival of Danish Prostate Cancer Patients, 1995-2006: A Population-Based Cohort Study.
    Urology. 2008;.
    PubMed     Related articles    Abstract available

  52. COLLI JL , Grant WB
    Solar ultraviolet B radiation compared with prostate cancer incidence and mortality rates in United States.
    Urology. 2008;71:531-5.
    PubMed     Related articles    Abstract available

  53. COHEN JK , Miller RJ Jr, Ahmed S, Lotz MJ, et al
    Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy.
    Urology. 2008;71:515-8.
    PubMed     Related articles    Abstract available

  54. KONETY BR , Sharp VJ, Raut H, Williams RD, et al
    Screening and management of prostate cancer in elderly men: the Iowa Prostate Cancer Consensus.
    Urology. 2008;71:511-4.
    PubMed     Related articles    Abstract available

  55. RAMALINGAM M , Lau W, Tan T, Fook S, et al
    Asians with localized prostate cancer treated with 3-dimensional conformal radiation therapy and adjuvant hormonal therapy: comparing Phoenix and American Society of Therapeutic Radiology and Oncology (ASTRO) definitions in an Asian population.
    Urology. 2008;71:506-10.
    PubMed     Related articles    Abstract available

  56. BENECCHI L , Pieri AM, Pastizzaro CD, Potenzoni M, et al
    Optimal measure of PSA kinetics to identify prostate cancer.
    Urology. 2008;71:390-4.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: